Cargando…
Dalbavancin safety in the phase 2/3 clinical development program
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088398/ http://dx.doi.org/10.1186/cc6248 |
| _version_ | 1782324938973118464 |
|---|---|
| author | Seltzer, E Goldberg, L Krause, D Simoneau, D Boudry, E |
| author_facet | Seltzer, E Goldberg, L Krause, D Simoneau, D Boudry, E |
| author_sort | Seltzer, E |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4088398 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40883982014-07-11 Dalbavancin safety in the phase 2/3 clinical development program Seltzer, E Goldberg, L Krause, D Simoneau, D Boudry, E Crit Care Poster Presentation BioMed Central 2008 2008-03-13 /pmc/articles/PMC4088398/ http://dx.doi.org/10.1186/cc6248 Text en Copyright © 2008 BioMed Central Ltd |
| spellingShingle | Poster Presentation Seltzer, E Goldberg, L Krause, D Simoneau, D Boudry, E Dalbavancin safety in the phase 2/3 clinical development program |
| title | Dalbavancin safety in the phase 2/3 clinical development program |
| title_full | Dalbavancin safety in the phase 2/3 clinical development program |
| title_fullStr | Dalbavancin safety in the phase 2/3 clinical development program |
| title_full_unstemmed | Dalbavancin safety in the phase 2/3 clinical development program |
| title_short | Dalbavancin safety in the phase 2/3 clinical development program |
| title_sort | dalbavancin safety in the phase 2/3 clinical development program |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088398/ http://dx.doi.org/10.1186/cc6248 |
| work_keys_str_mv | AT seltzere dalbavancinsafetyinthephase23clinicaldevelopmentprogram AT goldbergl dalbavancinsafetyinthephase23clinicaldevelopmentprogram AT kraused dalbavancinsafetyinthephase23clinicaldevelopmentprogram AT simoneaud dalbavancinsafetyinthephase23clinicaldevelopmentprogram AT boudrye dalbavancinsafetyinthephase23clinicaldevelopmentprogram |